Abstract: Each event type in a business process is represented by a node in a process discovery graph. Semantic clustering merges nodes based on a commonality between them. As a result, a graphical user interface (GUI) may be presented that shows fewer nodes. This process may be repeated, using different commonalities at each level. A user may select a node to zoom in, showing the constituent nodes. The frequency of an event or its other attribute values may be compared to a predetermined threshold to determine if the event is a blocking event. The GUI may indicate that the node for an event is a blocking event. When the node for the event is merged with other nodes using semantic clustering, the blocking status of the node is transferred to the merged node. After zooming in on the blocking event, the GUI allows the user to select the blocking event to cause display of a recommendation.

Abstract: The present disclosure provides techniques and solutions for benchmarking process models by evaluating characteristics of the model, such as those reflecting model complexity. Metrics can include the number of elements in a model, the number of roles, and the number of handoffs between roles, as a few examples. Metrics for a model can be compared with reference metrics, such as those calculated from a set of other models, which can be for the same modeled process or different processes. Collections of process models can be evaluated in a similar manner, including for a set of related models that may be expressed at different levels of specificity. Metrics for individual models in the collection can be evaluated and aggregated, and then compared with aggregated metric values of other model collections, for the same or different modeled processes.

Abstract: Large enterprises often modify standard process templates provided by software vendors to better suit their organizational processes. These modifications, which can include tracking new types of events or using modified event definitions, are typically difficult for the software vendor to detect. However, they can represent improvements to the template that could provide enhanced functionality for other organizations. The present disclosure provides techniques and solutions for detecting and analyzing such modifications made by organizations. It determines whether a subset of these modifications are semantically equivalent and whether they satisfy a threshold. If the threshold is satisfied, the process template is updated to include a modification of the semantically equivalent modifications, providing an updated version of the standard template that can be provided to other organizations.

Abstract: Personal care compositions comprising an active component, use of such compositions, and methods of marketing such compositions. In one embodiment, the active component comprises pear seed extract. The personal care compositions can be applied topically, ingested orally, injected, or used as part of a regimen.

Abstract: Personal care compositions comprising an active component, use of such compositions, and methods of marketing such compositions. The personal care compositions can be applied topically, ingested orally, injected, or used as part of a regimen.

Abstract: Personal care compositions comprising a PPARG antagonist, use of such compositions, and methods of marketing such compositions. The personal care compositions can be applied topically, ingested orally, injected, or used as part of a regimen.

Abstract: Compounds suitable for treating multidrug resistance and methods for their preparation and use are disclosed. The compounds are represented by the following formula: or an optical isomer, diastereomer, enantiomer or pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to a topical skin care composition containing a safe and effective amount of a skin care active comprising agmatine, and its salt; a safe and effective amount of a first additional skin care active selected from the group consisting of BHT or BHA, hexamidine, cetyl pyridinium chloride, green tea catechins, phytosterols, ursolic acid, compounds derived from plant extracts, their salts and derivatives; and a dermatologically acceptable carrier for the agmatine composition. The present invention also relates to methods of using such agmatine compositions to regulate hair growth and the condition of mammalian skin. Said methods generally comprise the step of topically applying the composition to the skin of a mammal needing such treatment, a safe and effective amount of such compositions.

Abstract: The present invention relates to a topical skin care composition containing a safe and effective amount of a skin care active comprising agmatine, and its salt; a safe and effective amount of a first additional skin care active selected from the group consisting of BHT or BHA, hexamidine, cetyl pyridinium chloride, green tea catechins, phytosterols, ursolic acid, compounds derived from plant extracts, their salts and derivatives; and a dermatologically acceptable carrier for the agmatine composition. The present invention also relates to methods of using such agmatine compositions to regulate hair growth and the condition of mammalian skin. Said methods generally comprise the step of topically applying the composition to the skin of a mammal needing such treatment, a safe and effective amount of such compositions.